The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Histopathologic and demographic features of non-small cell lung cancer in patients with BRCA pathogenic germline variants.
 
Benjamin Bleiberg
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Janssen Oncology
 
Michael Wang
No Relationships to Disclose
 
Caitlin Orr
No Relationships to Disclose
 
Katie Cappola
No Relationships to Disclose
 
Abigail Doucette
No Relationships to Disclose
 
Heena Desai
No Relationships to Disclose
 
Ryan Hausler
No Relationships to Disclose
 
Bradley Wubbenhorst
No Relationships to Disclose
 
Peter Gabriel
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Layer Health
Travel, Accommodations, Expenses - National Comprehensive Cancer Network
 
Kate Nathanson
No Relationships to Disclose
 
Andrew Haas
Stock and Other Ownership Interests - Serpex Medical
Consulting or Advisory Role - Novocure; Olympus; Serpex Medical
 
Melina Marmarelis
Stock and Other Ownership Interests - Johnson & Johnson; Merck
Honoraria - AstraZeneca; Blueprint Medicines; Janssen Oncology; Novocure; Takeda; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; NEUVOGEN; Regeneron
Research Funding - AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Susan Domchek
Honoraria - Intellia Therapeutics
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst)
 
Kara Maxwell
No Relationships to Disclose